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ANTIARRIMMMIC HODIFICATION OF INDUCED VENTRICULAR 
TACHYCARUIA; DOES IT PREDICT TYPE OF RECURRENT ARFUiYTHMIC 
EVENT? 
Nichael Uihelvi. 
Ellison Berns, Jane R. Fisher, and 
Hartford Hospital and The University of 
Connect&, hartford, CT 
Pts with inducible (IND) sustained monomorphic ventri- 
cular tachycardia (VT) at baseline electrsphysiology 
study (EPS) underwent serial drug testing. Ninety six pts 
presented with cardiac arrest (n-30), VT (n-56), or 
syncope (n-10). Pts were divided into 3 groups based on 
their pre-discharge drug EPS: Group I (n-41) were 
noninducible (NI) (515 beats), Group II (n-32) IND 
modified VT (ZlOOmsec increase in VT cycle length, 
systolic blood pressure T9OmmHg and no symptoms), Group 
III (n-23) IND unmodified VT. There were no significant 
differences among the Groups in presenting arrhythmia, 
type of heart disease (84% coronary artery disease) and 
mean ejection fraction (36flSX). Amiodarone use was 
greater in Group III vs Group I (pC.02) but not Group II. 
Pts were followed for 18f19 months for recurrent VT, 
sudden cardiac death (SCD), and total mortality. 
Group I Group II Group111 
Recurrent VT* 3(7X) 9(28X) 7(30X) 
Sudden cardiac death 2(5X) 1(3%) 1(4X) 
Total mortality 8(20X) 5(16X) 4(17X) 
* pc.025 Group I vs II and III 
In pts presenting with cardiac arrest, 3 (10%) had SCD on 
follow-up irrespective of pre-discharge EPS results vs 
only 1 (1.5%) who presented with VT or syncope (p-.08). 
Conclusion: Noninducibility predicts a reduction in 
recurrent VT, but persistent inducibility whether 
modified or unmodified on pharmacologic therapy may not 
predict sudden cardiac death. Furthermore, the incidence 
of SCD on pharmacologic therapy is negligible in pts who 
presented with VT or syncope irrespective of pre- 
discharge EPS. 
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CAN ACUTE DRUG TESTING WITH PROGRAMMED STIM- 
ULATION PREDICT POTENTIAL “ROARRHYIHMIC EFFECTS 
Belinda Flares, Mark E. loseuhson. Alfred E. 
Buxton. University of Pennsylvania, Philadelphia, P&sylvania. 
We sought to determine if acute drug testing with programmed 
stimulation (PS) can identify pts at risk for potential proarrhythmic 
effects of type 1A agents. We studied 80 pts with prior myocardial 
infarction and spontaneous hemodynamically stable sustained 
ventricular tachycardia (VT-s). Spontaneous VT-s occurred in 30 
patients (group 1) only during therapy with a type 1A agent 
(procFnamtde(PA)-22, quinidine-8), and in SO pts (group 2) receiving 
no anttarrhythmic therapy. Groups were similar with respect to age, 
sex, extent of CAD and ejection fraction. All pts underwent PS in the 
drug free state and after PA IV loading (lSmg/kg). PS included burst 
pacing and up to 3 extrastimuli at 2 RV sites and 2 2 cycle lengths. 
4VT induction(Mxtrastim) 
&&& i$c;uc)” AVERP(%) AVTCW) Nl Same mm tess 
28 (93%) +9k7 +33*19 1 11 4 13 
47 (94%) 
PA 45 (90%) +lOkl +26?15 2 26 3 16 
No sign. difference bctwecn group 1 and 2 for all categories; +- pts with same morph- 
ology VT-s before and afm PA, 
l.Pts with prior myocardial infarction who have spontaneous VT-s only 
on type 1A agents have a similar frequency of induced VT-s as those 
who present with VT-s off drugs. 2, The change in VERP and VT-s 
cycle length after PA was similar in both groups. 3. In the majority of 
pts, regardless of presentation, the same number or fewer extrastimuli 
were needed to induce VT-s after PA. Thus, baseline PS and acute PA 
drug testing with PS failed to identify pts whose spontaneous VT-s 
occurred only while on drug therapy. Therefore, either testing is of 
limited value in identifying potential proarrhythmic drug effects, or 
spontaneous VT-s during drug therapy rarely represents a pmrrhythmic 
effect of the therapy. 
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DOPPLER ECHOCARDIOGRAPHY OF AORTIC VALVE ALLOGRAFTS AND 
PULMONARY AUTOGRAFTS: A COMPARISON OF FREE-HAND VALVE 
MD AORTIC ROOT REPLACEMENT 
Victor 6. Davila-Roman, Benico Barzilai, Suran Murphy, 
Peggy Brown, Nicholas T. Kouchoukos. Washington Univ- 
ersity, St. Louis, MO 
Aortic Insufficiency (AI1 occurs c only following aor- 
tic valve replacement with free-hand aortlc allografts. 
The purpose of this study was to define the Incidence of 
AI following root replacement (aortlc allograft or pul- 
manic autograft). Twelve patients having aortic root 
replacement with aortlc allografts (6) or pulmonic auto- 
grafts (6) (Grp. I) and 16 patlents having aortic valve 
replacement with free-hand aortic allografts (Grp. II) 
had echocardlographic evaluation with 2-D, Doppler and 
color flow imaging (CFI) early after surgery (< 2 weeks) 
and at 3-6 month intervals thereafter. The an follow- 
up was 7.5 months (range 3-13) for Grp. I and 10 months 
(range 4-18) for Gro. II. 
Early foil W-UP Intermediate follow-up 
No. AI AV pk No. AV pk 
Pts 
r 6; 
vel* 
Grp.1 12 
P's' # ;:s vel* 
Grp.11 16 8 (rn) ::; 
3 (2mJmoI 1.5 
14 9 (6m,3mol 1.7 
m=mlld; mo=moderate; AI=aortic insufficiency; *m/s 
Results: 1) CFI detected AI in I/12 (8%) in Grp. I ws 
-0%) in Grp. II in the early F/u period 
this difference persisted at 
(p - .02); 
inte 
(33%) vs Grp. II 9/14 (64X; p = N 
bited AI greater than moderate in 
significant difference between th 
peak aortic velocity by Doppler. 
on after free-hand valve allogra 
root replacement as detected by Doppler techniques. 
